| Name | Title | Contact Details |
|---|
Preferred Health Strategies is a Rye, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
himagine solutions inc. is a leading healthcare outsourcing solutions provider with the largest team of inpatient and outpatient coders in the U.S. Our professional HIM outsourcing services include basic staff augmentation as well as more strategic managed coding solutions including full department outsourcing through our Enterprise HIM offering to support more than 250 healthcare providers across the U.S. With our significant and growing base of HIM Subject Matter Experts we provide support for all of our offerings to ensure our client partners receive the most value from our services.
Headquartered in Jacksonville, FL, Healogics is the nation`s largest provider of advanced wound care services. Healogics and its affiliated companies manage a network of Wound Care Centers® through-out the United States and the United Kingdom. Healogics technology-enabled wound care model supports the critical connection between patients with chronic wounds and multi-disciplinary teams for continuous, collaborative, patient-centered care.
PDI Inc. is a provider of contract sales teams to pharmaceutical companies, offering a range of sales support services.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.